The U.S. Supreme Court has upheld the constitutionality of the U.S. Preventive Services Task Force, saving free PrEP and other preventive treatments, including screenings for...
FDA approves PrEP drug. Lenacapavir is a twice-yearly HIV prevention shot more effective than daily pills.
The telehealth platform MISTR reports that its efforts to connect patients with DoxyPEP has led to a more than 50% drop in STI diagnoses.
A new study claims that almost 11 million more HIV infections, and 3 million deaths, could result from the loss of global HIV funding.
Organizers are hoping to raise at least $550,000 to benefit Whitman-Walker's HIV testing, treatment, and prevention services.
A recent study has found that lenacapavir, an injectable medication administered twice a year, is more effective at preventing HIV among gay, bisexual, and transgender...
Proceeds from annual fundraiser directly benefit Whitman-Walker Health's HIV testing, outreach, and treatment programs.
The number of new HIV infections has dropped from five years ago, with experts pointing to increased PrEP use as the primary reason.
Whitman-Walker Health, the federally-qualified health center that specializes in HIV-related and LGBTQ-competent care, has declared its “Walk to End HIV” a success after exceeding its...
Texas judge claims requiring employers to provide insurance coverage for HIV prevention drugs violates their religious beliefs.
Almost 9 in 10 Americans say there is stigma around HIV, but also say improvements in HIV treatment have been made
Local organization is distributing "senior care kits" and food packages to vulnerable LGBTQ community members
Grants were made possible through Gilead Sciences' TRANScend Community Impact Fund
Grants given to 15 transgender-led organizations to try and improve trans health outcomes
Human rights activists say that attacks on LGBTQ Ugandans have increased ever since elected leaders began churning up support for a revival of an anti-gay...